All contributors
Onconephrology contributor
Pazdur, Richard
Primarily Anti-VEGF / TKI renal effects
10
Clinical papers
1,813
Citations (iCite)
0 / 9
First / senior author
2003–2021
Active years
Subfield mix
Clinical papers by onconephrology subfield (a paper can count in more than one).
Anti-VEGF / TKI renal effects7
Myeloma cast nephropathy2
Anticancer drug nephrotoxicity1
Checkpoint-inhibitor kidney injury1
Agents they study
Catalog agents whose clinical kidney literature lists Pazdur among the leading contributors.
Verify
Representative recent papers, and this author’s full PubMed bibliography.
A code-tallied bibliometric profile from PubMed + NIH iCite, restricted to human/clinical papers (regenerated 2026-07-08). Recognition of published contribution — not a verdict on merit or influence, and not medical advice.